Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-14-049422

Director acquired 76 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
POHOTSKY OLEG M Director 2014-06-24 Option exercise +76 $19.75 $1,501 305 D
Derivatives
POHOTSKY OLEG M Director 2014-06-24 Option exercise · Subscription Rights −228 0 D
Loading xslF345X03/a4.xml…